Results Baseline characteristics in the study population This analysis compared five anti-obesity medications, examining demographic characteristics, comorbidities, medication use, and laboratory markers before and after PSM (Supplementary Fig
For most patients, reaching goal weight does not signal the end of treatment but rather a transition from the weight loss phase to the weight maintenance phase, which typically requires continued pharmacological support for optimal outcomes as long as benefits outweigh risks
While this is beneficial for weight management and blood sugar regulation, it also changes how digestion feels day to day
Serious adverse events remain rare and comparable to placebo rates in controlled trials
PlexusDx's Precision Peptide Genetic Test includes genetic context that may help clarify your oxidative stress susceptibility and inform whether targeted supplementation or lifestyle interventions warrant priority in your wellness framework
The random effects models wide confidence intervals showed that the estimates varied